Paediatric rheumatology AB0944 USE,SAFETY AND EFFICACY OF ETANERCEPT IN JIA-A SINGLE CENTRE RETROSPECTIVE STUDY FROM NORTH INDIA
Background: Juvenile idiopathic arthritis (JIA) is the most common chronic inflammatory arthritis in children. The International League of Associations for Rheumatology 2001 (ILAR) classification includes 7 subgroups: systemic JIA, polyarticular JIA, oligoarticular JIA, enthesitis related arthritis (ERA), psoriatic arthritis and undifferentiated arthritis. Most paediatric inflammatory arthritides persist into adulthood. Therefore, a transition from paediatric to adult rheumatology is a necessary step. Transition is defined as an active process by which a young patient with a chronic disease develops skills and resources to gradually take control of their condition. The transition phase should be anticipated and structured because of the risk of failure in monitoring. However difference in classification criteria in paediatric and adult rheumatology can cause significant difficulty for adult rheumatologists. Objectives: The aim of this study was to determine the characteristics of juvenile-onset arthritis seen during the transition period and to compare paediatric classification criteria to those of adults. Methods: A retrospective bi-centre study was performed. Patients with JIA according to ILAR classification were included and had a consultation at transition. JIA classification criteria were compared to ACR/EULAR 2010 criteria
